Ira Palmer

3.3k total citations
24 papers, 1.6k citations indexed

About

Ira Palmer is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Ira Palmer has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Virology and 5 papers in Infectious Diseases. Recurrent topics in Ira Palmer's work include HIV Research and Treatment (6 papers), Protein purification and stability (5 papers) and Hepatitis B Virus Studies (4 papers). Ira Palmer is often cited by papers focused on HIV Research and Treatment (6 papers), Protein purification and stability (5 papers) and Hepatitis B Virus Studies (4 papers). Ira Palmer collaborates with scholars based in United States, Taiwan and United Kingdom. Ira Palmer's co-authors include Paul T. Wingfield, Joshua D. Kaufman, Stephen J. Stahl, Alan Engelman, Robert Craigie, Frederic D. Bushman, Ad Bax, Stephan Grzesiek, Jinshan Hu and Angela M. Gronenborn and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ira Palmer

24 papers receiving 1.5k citations

Peers

Ira Palmer
Matthew J. Fivash United States
Douglas F. Lake United States
Luc Selig France
Lorraine Everitt United States
Peter V. Pallai United States
Stephen Oroszlan United States
Henry J. George United States
Marc C. Deller United States
Larry J. Ross United States
Jason J. Stephany United States
Matthew J. Fivash United States
Ira Palmer
Citations per year, relative to Ira Palmer Ira Palmer (= 1×) peers Matthew J. Fivash

Countries citing papers authored by Ira Palmer

Since Specialization
Citations

This map shows the geographic impact of Ira Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Palmer more than expected).

Fields of papers citing papers by Ira Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Palmer. The network helps show where Ira Palmer may publish in the future.

Co-authorship network of co-authors of Ira Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Ira Palmer. A scholar is included among the top collaborators of Ira Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira Palmer. Ira Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watts, Norman R., Elif Eren, Ira Palmer, et al.. (2023). The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2. PLoS ONE. 18(6). e0286370–e0286370. 3 indexed citations
2.
Eren, Elif, Norman R. Watts, Altaira D. Dearborn, et al.. (2018). Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition. Structure. 26(10). 1314–1326.e4. 15 indexed citations
3.
Dearborn, Altaira D., Elif Eren, Norman R. Watts, et al.. (2018). Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association. Structure. 26(9). 1187–1195.e4. 16 indexed citations
4.
Watts, Norman R., Joshua D. Kaufman, Ira Palmer, et al.. (2017). Expression and Purification of ZASP Subdomains and Clinically Important Isoforms: High-Affinity Binding to G-Actin. Biochemistry. 56(14). 2061–2070. 7 indexed citations
5.
Yedidi, Ravikiran S., Kenji Maeda, David A. Davis, et al.. (2013). P2′ Benzene Carboxylic Acid Moiety Is Associated with Decrease in Cellular Uptake: Evaluation of Novel Nonpeptidic HIV-1 Protease Inhibitors Containing P2 bis -Tetrahydrofuran Moiety. Antimicrobial Agents and Chemotherapy. 57(10). 4920–4927. 25 indexed citations
6.
Palmer, Ira & Paul T. Wingfield. (2012). Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli. Current Protocols in Protein Science. 70(1). 68 indexed citations
7.
Stahl, Stephen J., Norman R. Watts, Christoph Rader, et al.. (2010). Generation and Characterization of a Chimeric Rabbit/Human Fab for Co-Crystallization of HIV-1 Rev. Journal of Molecular Biology. 397(3). 697–708. 29 indexed citations
8.
Zhang, Fan, Hongfang Qiu, Stephen J. Stahl, et al.. (2009). Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo. Journal of Biological Chemistry. 285(4). 2438–2455. 61 indexed citations
9.
Dolinska, Monika B., Yuri V. Sergeev, May P. Chan, Ira Palmer, & Paul T. Wingfield. (2009). N-Terminal Extension of βB1-Crystallin: Identification of a Critical Region That Modulates Protein Interaction with βA3-Crystallin. Biochemistry. 48(40). 9684–9695. 24 indexed citations
10.
Palmer, Ira & Paul T. Wingfield. (2004). Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli. Current Protocols in Protein Science. 38(1). 6.3.1–6.3.18. 130 indexed citations
11.
12.
Zlotnick, Adam, Ira Palmer, Joshua D. Kaufman, et al.. (1999). Separation and crystallization ofT= 3 andT= 4 icosahedral complexes of the hepatitis B virus core protein. Acta Crystallographica Section D Biological Crystallography. 55(3). 717–720. 32 indexed citations
13.
Wang, Yun‐Xing, Nouri Neamati, Jaison Jacob, et al.. (1999). Solution Structure of Anti-HIV-1 and Anti-Tumor Protein MAP30. Cell. 99(4). 433–442. 63 indexed citations
14.
Wingfield, Paul T., Joanna K. Sax, Stephen J. Stahl, et al.. (1999). Biophysical and Functional Characterization of Full-length, Recombinant Human Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Produced in Escherichia coli. Journal of Biological Chemistry. 274(30). 21362–21368. 92 indexed citations
15.
Grzesiek, Stephan, Ad Bax, Jinshan Hu, et al.. (1997). Refined solution structure and backbone dynamics of HIV‐1 Nef. Protein Science. 6(6). 1248–1263. 138 indexed citations
16.
Grzesiek, Stephan, Ad Bax, G. Marius Clore, et al.. (1996). The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Structural & Molecular Biology. 3(4). 340–345. 299 indexed citations
17.
Palmer, Ira & Paul T. Wingfield. (1995). Preparation and Extraction of Insoluble (Inclusion‐Body) Proteins from Escherichia coli. Current Protocols in Protein Science. 0(1). 3 indexed citations
18.
Hickman, Alison B., Ira Palmer, Alan Engelman, Robert Craigie, & Paul T. Wingfield. (1994). Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase.. Journal of Biological Chemistry. 269(46). 29279–29287. 68 indexed citations
19.
Bushman, Frederic D., Alan Engelman, Ira Palmer, Paul T. Wingfield, & Robert Craigie. (1993). Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.. Proceedings of the National Academy of Sciences. 90(8). 3428–3432. 316 indexed citations
20.
Becerra, S. Patricia, Ira Palmer, Arun Kumar, et al.. (1993). Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor.. Journal of Biological Chemistry. 268(31). 23148–23156. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew J. Fivash Breakdown of academic impact, for papers by Douglas F. Lake Breakdown of academic impact, for papers by Luc Selig Breakdown of academic impact, for papers by Lorraine Everitt Breakdown of academic impact, for papers by Peter V. Pallai Breakdown of academic impact, for papers by Stephen Oroszlan Breakdown of academic impact, for papers by Henry J. George Breakdown of academic impact, for papers by Marc C. Deller Breakdown of academic impact, for papers by Larry J. Ross Breakdown of academic impact, for papers by Jason J. Stephany
Rankless by CCL
2026